Invention Grant
- Patent Title: Tricyclic heterocycles as bet protein inhibitors
- Patent Title (中): 三环杂环作为蛋白质抑制剂
-
Application No.: US14212721Application Date: 2014-03-14
-
Publication No.: US09227985B2Publication Date: 2016-01-05
- Inventor: Andrew P. Combs , Richard B. Sparks , Thomas P. Maduskuie , James D. Rodgers
- Applicant: Incyte Corporation
- Applicant Address: US DE Willmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Willmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D498/16
- IPC: C07D498/16 ; C07D471/06 ; C07D498/06
Abstract:
The present invention relates to tricyclic heterocycles of Formula (I): which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20140275030A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS Public/Granted day:2014-09-18
Information query
